What’s New

News Nov 18, 2024
Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial

September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality…

Interview Jul 19, 2024
Expanding the Alimentiv Site Network: An Interview With Peter Westerveld

The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring…

Publication Jun 28, 2023
Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn’s Disease: Systematic Review and Meta-Analysis
Publication Jun 15, 2023
Efficacy and safety of advanced oral small molecules for inflammatory bowel disease: Systematic review and meta-analysis
Publication Jun 10, 2023
Standardizing Scoring Conventions for Crohn’s Disease Endoscopy: An International RAND/UCLA Appropriateness Study
Publication Jun 2, 2023
Targeting IL-23 for IBD: Rationale and Progress to Date
Publication May 29, 2023
Effect of storage time on peripheral blood mononuclear cell isolation from blood collected in vacutainer CPT™ tubes
Publication May 29, 2023
Effect of storage time on peripheral blood mononuclear cell isolation from blood collected in vacutainer CPT™ tubes